Logo image of KSI.CA

KNEAT.COM INC (KSI.CA) Stock Fundamental Analysis

TSX:KSI - Toronto Stock Exchange - CA4988241010 - Common Stock - Currency: CAD

5.83  -0.36 (-5.82%)

Fundamental Rating

4

KSI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 8 industry peers in the Health Care Technology industry. While KSI seems to be doing ok healthwise, there are quite some concerns on its profitability. KSI is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year KSI has reported negative net income.
In the past year KSI had a positive cash flow from operations.
In the past 5 years KSI always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: KSI reported negative operating cash flow in multiple years.
KSI.CA Yearly Net Income VS EBIT VS OCF VS FCFKSI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

KSI has a Return On Assets of -1.64%. This is amongst the best in the industry. KSI outperforms 87.50% of its industry peers.
KSI has a Return On Equity of -3.35%. This is amongst the best in the industry. KSI outperforms 87.50% of its industry peers.
Industry RankSector Rank
ROA -1.64%
ROE -3.35%
ROIC N/A
ROA(3y)-15.47%
ROA(5y)-16.49%
ROE(3y)-45.71%
ROE(5y)-39.12%
ROIC(3y)N/A
ROIC(5y)N/A
KSI.CA Yearly ROA, ROE, ROICKSI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

Looking at the Gross Margin, with a value of 75.11%, KSI is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Gross Margin of KSI has grown nicely.
The Profit Margin and Operating Margin are not available for KSI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.7%
GM growth 5Y11.01%
KSI.CA Yearly Profit, Operating, Gross MarginsKSI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

5

2. Health

2.1 Basic Checks

KSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KSI has more shares outstanding
The number of shares outstanding for KSI has been increased compared to 5 years ago.
The debt/assets ratio for KSI has been reduced compared to a year ago.
KSI.CA Yearly Shares OutstandingKSI.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
KSI.CA Yearly Total Debt VS Total AssetsKSI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

KSI has an Altman-Z score of 4.57. This indicates that KSI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.57, KSI is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
A Debt/Equity ratio of 0.36 indicates that KSI is not too dependend on debt financing.
KSI has a Debt to Equity ratio of 0.36. This is in the better half of the industry: KSI outperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 4.57
ROIC/WACCN/A
WACC7.49%
KSI.CA Yearly LT Debt VS Equity VS FCFKSI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

KSI has a Current Ratio of 1.91. This is a normal value and indicates that KSI is financially healthy and should not expect problems in meeting its short term obligations.
KSI has a Current ratio of 1.91. This is in the better half of the industry: KSI outperforms 62.50% of its industry peers.
KSI has a Quick Ratio of 1.91. This is a normal value and indicates that KSI is financially healthy and should not expect problems in meeting its short term obligations.
KSI has a better Quick ratio (1.91) than 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.91
KSI.CA Yearly Current Assets VS Current LiabilitesKSI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

KSI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.95%, which is quite impressive.
Looking at the last year, KSI shows a very strong growth in Revenue. The Revenue has grown by 42.93%.
KSI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 65.43% yearly.
EPS 1Y (TTM)78.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)42.93%
Revenue growth 3Y46.7%
Revenue growth 5Y65.43%
Sales Q2Q%36.97%

3.2 Future

KSI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.05% yearly.
Based on estimates for the next years, KSI will show a very strong growth in Revenue. The Revenue will grow by 30.40% on average per year.
EPS Next Y16.67%
EPS Next 2Y33.14%
EPS Next 3Y46.05%
EPS Next 5YN/A
Revenue Next Year38.63%
Revenue Next 2Y36.87%
Revenue Next 3Y33.84%
Revenue Next 5Y30.4%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
KSI.CA Yearly Revenue VS EstimatesKSI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M 250M
KSI.CA Yearly EPS VS EstimatesKSI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 -0.1 -0.15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KSI. In the last year negative earnings were reported.
Also next year KSI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KSI.CA Price Earnings VS Forward Price EarningsKSI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 -200

4.2 Price Multiples

75.00% of the companies in the same industry are more expensive than KSI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 83.85
KSI.CA Per share dataKSI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

KSI's earnings are expected to grow with 46.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.14%
EPS Next 3Y46.05%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KSI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KNEAT.COM INC

TSX:KSI (6/18/2025, 7:00:00 PM)

5.83

-0.36 (-5.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04
Inst Owners13.73%
Inst Owner ChangeN/A
Ins Owners9.82%
Ins Owner ChangeN/A
Market Cap550.35M
Analysts80
Price Target8.36 (43.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)90.1%
Min EPS beat(2)0.99%
Max EPS beat(2)179.21%
EPS beat(4)4
Avg EPS beat(4)76.01%
Min EPS beat(4)0.99%
Max EPS beat(4)179.21%
EPS beat(8)7
Avg EPS beat(8)32.59%
EPS beat(12)10
Avg EPS beat(12)28.74%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.97%
Min Revenue beat(2)-4.23%
Max Revenue beat(2)-1.71%
Revenue beat(4)1
Avg Revenue beat(4)-0.88%
Min Revenue beat(4)-4.23%
Max Revenue beat(4)2.47%
Revenue beat(8)3
Avg Revenue beat(8)-1.04%
Revenue beat(12)6
Avg Revenue beat(12)0.67%
Revenue beat(16)10
Avg Revenue beat(16)4.72%
PT rev (1m)-1.8%
PT rev (3m)4.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)6.25%
Revenue NQ rev (1m)-1.87%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.4
P/FCF N/A
P/OCF 29.17
P/B 8.22
P/tB 19.81
EV/EBITDA 83.85
EPS(TTM)-0.04
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.2
OCFY3.43%
SpS0.56
BVpS0.71
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.64%
ROE -3.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.11%
FCFM N/A
ROA(3y)-15.47%
ROA(5y)-16.49%
ROE(3y)-45.71%
ROE(5y)-39.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.7%
GM growth 5Y11.01%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA 4.01
Cap/Depr 184.84%
Cap/Sales 38.89%
Interest Coverage N/A
Cash Conversion 312.65%
Profit Quality N/A
Current Ratio 1.91
Quick Ratio 1.91
Altman-Z 4.57
F-Score6
WACC7.49%
ROIC/WACCN/A
Cap/Depr(3y)219.46%
Cap/Depr(5y)224.77%
Cap/Sales(3y)49.12%
Cap/Sales(5y)62.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y16.67%
EPS Next 2Y33.14%
EPS Next 3Y46.05%
EPS Next 5YN/A
Revenue 1Y (TTM)42.93%
Revenue growth 3Y46.7%
Revenue growth 5Y65.43%
Sales Q2Q%36.97%
Revenue Next Year38.63%
Revenue Next 2Y36.87%
Revenue Next 3Y33.84%
Revenue Next 5Y30.4%
EBIT growth 1Y58.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year258.01%
EBIT Next 3Y81.73%
EBIT Next 5Y48.14%
FCF growth 1Y84.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y515.27%
OCF growth 3Y61.83%
OCF growth 5YN/A